GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sandoz Group AG (OTCPK:SDZNY) » Definitions » Return-on-Tangible-Asset

Sandoz Group AG (Sandoz Group AG) Return-on-Tangible-Asset : 3.25% (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Sandoz Group AG Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Sandoz Group AG's annualized Net Income for the quarter that ended in Dec. 2023 was $308 Mil. Sandoz Group AG's average total tangible assets for the quarter that ended in Dec. 2023 was $9,473 Mil. Therefore, Sandoz Group AG's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2023 was 3.25%.

The historical rank and industry rank for Sandoz Group AG's Return-on-Tangible-Asset or its related term are showing as below:

SDZNY' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 0.79   Med: 5.29   Max: 9.79
Current: 0.79

During the past 2 years, Sandoz Group AG's highest Return-on-Tangible-Asset was 9.79%. The lowest was 0.79%. And the median was 5.29%.

SDZNY's Return-on-Tangible-Asset is ranked worse than
53.88% of 1082 companies
in the Drug Manufacturers industry
Industry Median: 1.84 vs SDZNY: 0.79

Sandoz Group AG Return-on-Tangible-Asset Historical Data

The historical data trend for Sandoz Group AG's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sandoz Group AG Return-on-Tangible-Asset Chart

Sandoz Group AG Annual Data
Trend Dec22 Dec23
Return-on-Tangible-Asset
9.79 0.81

Sandoz Group AG Quarterly Data
Dec22 Dec23
Return-on-Tangible-Asset 39.14 3.25

Competitive Comparison of Sandoz Group AG's Return-on-Tangible-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Sandoz Group AG's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sandoz Group AG's Return-on-Tangible-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sandoz Group AG's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Sandoz Group AG's Return-on-Tangible-Asset falls into.



Sandoz Group AG Return-on-Tangible-Asset Calculation

Sandoz Group AG's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=77/( (8666+10279)/ 2 )
=77/9472.5
=0.81 %

Sandoz Group AG's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Dec. 2022 )(Q: Dec. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Dec. 2022 )(Q: Dec. 2023 )
=308/( (8666+10279)/ 2 )
=308/9472.5
=3.25 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Dec. 2023) net income data.


Sandoz Group AG  (OTCPK:SDZNY) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Sandoz Group AG Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Sandoz Group AG's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Sandoz Group AG (Sandoz Group AG) Business Description

Traded in Other Exchanges
Address
Forum 1, Novartis Campus, Basel, CHE, CH-4056
Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $9 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006 as well as U.S.'s first biosimilar, Zarxio, in 2015. It currently has eight commercialized biosimilars in a number of markets and has over 20 assets in pipeline.

Sandoz Group AG (Sandoz Group AG) Headlines

From GuruFocus

Q3 2023 Sandoz Group AG Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2023 Sandoz Group AG Earnings Call Transcript

By GuruFocus Research 02-14-2024